— Focused on Global Healthcare Innovation Investment and Advancing Medical Philanthropy in Africa
Japan Medical Foundation Announces Over $500 Million in Long-Term Global Strategic Partnerships to Drive Healthcare Innovation.
The Japan Medical Foundation (JMF), a general incorporated foundation, recently announced the establishment of long-term strategic partnerships totaling over USD 500 million with multiple international institutions. This collaboration aims to jointly promote investment in innovative projects across the global healthcare sector, with a focus on eight key areas: precision medicine, biopharmaceuticals, digital health, medical data infrastructure, and more.
Founded in 2018, the Japan Medical Foundation is an innovation-driven institution dedicated to global healthcare investment. In collaboration with leading healthcare organizations worldwide, JMF has established a Global Strategic Medical Alliance with total assets under management exceeding USD 3.8 billion.
This round of strategic partnerships includes international medical technology group HealthNext Holdings, Americas-based senior healthcare and wellness asset manager SilverPath Capital, emerging markets healthcare accelerator Afrinova MedTech, and institutional collaborators such as the World Health Organization (WHO) Europe Office, European Medicines Agency (EMA), the UK National Health Service (NHS), Roche (Switzerland), the Pasteur Institute (France), Philips Healthcare (Netherlands), Karolinska Institutet (Sweden), UZ Leuven (Belgium), and Novo Nordisk (Denmark). The parties will cooperate across capital investment, technological co-development, and cross-border regulatory coordination to jointly build a sustainable global healthcare ecosystem.
As the core facilitator of this initiative, JMF has consistently focused on long-term value investment in healthcare since its inception, with special attention to accessibility and affordability in aging societies. Staying true to its public welfare mission, JMF actively fulfills its social responsibility. In recent years, the foundation has supported healthcare infrastructure development and philanthropic projects across African nations, funding initiatives such as the Comprehensive Medical Station Project in remote Kenya and Maternal Rescue Network Plan in Nigeria, benefitting hundreds of thousands of grassroots patients.
JMF’s specialized medical wealth management platform, ShinTrust Capital, leverages JMF’s globally diversified investment portfolio and in-depth industry research capabilities. Over the past three years, ShinTrust Capital has achieved a steady annualized return of 11.8%, with a three-year compound growth rate of 13.5%. The fund primarily invests in regenerative medicine, AI-assisted diagnostic platforms, cross-border medical insurance, and wearable remote monitoring technologies—projects known for their cutting-edge innovation and long-term sustainability potential.
The Chairman of JMF stated:
“Healthcare is more than an industry—it is a global responsibility. Through collaborative innovation with our international partners, we aim not only to generate investment returns but also to contribute to health equity around the world.”
Looking ahead, JMF will continue to expand the global presence of ShinTrust Capital, enhance the systemization, compliance, and digital management of medical investments, and lead the evolving intersection of healthcare and finance into the next era.
